Intec Pharma Ltd.
- Country
- 🇮🇱Israel
- Ownership
- Private, Subsidiary
- Established
- 2000-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://intecpharma.com
Clinical Trials
18
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (18 trials with phase data)• Click on a phase to view related trials
Study to Assess Pharmacokinetics of Accordion Pill Carbidopa-Levodopa Compared to Immediate Release Carbidopa-Levodopa in Parkinson's Disease Patients
- Conditions
- Parkinson Disease
- Interventions
- Drug: Accordion Pill Carbidopa/Levodopa
- First Posted Date
- 2018-07-03
- Last Posted Date
- 2018-07-05
- Lead Sponsor
- Intec Pharma Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT03576638
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
- Conditions
- Parkinson's Disease
- Interventions
- Drug: Accordion Pill™ Carbidopa/Levodopa
- First Posted Date
- 2015-11-26
- Last Posted Date
- 2018-08-14
- Lead Sponsor
- Intec Pharma Ltd.
- Target Recruit Count
- 460
- Registration Number
- NCT02615873
- Locations
- 🇺🇸
University Alabama Hospital Neurology, Birmingham, Alabama, United States
🇺🇸Saint Joseph's Hospital and Medical Center Muhammad Ali Parkinson Research Center, Phoenix, Arizona, United States
🇺🇸Banner Sun Health Research Institute, Sun City, Arizona, United States
A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients
- Conditions
- Parkinson's Disease
- Interventions
- First Posted Date
- 2015-11-16
- Last Posted Date
- 2019-08-08
- Lead Sponsor
- Intec Pharma Ltd.
- Target Recruit Count
- 420
- Registration Number
- NCT02605434
- Locations
- 🇺🇸
University Alabama Hospital Neurology, Birmingham, Alabama, United States
🇺🇸Saint Joseph's Hospital and Medical Center Muhammad Ali Parkinson Research Center, Phoenix, Arizona, United States
🇺🇸Parkinson's Disease & Movement Disorders Center, Dept of Neu, Fountain Valley, California, United States
A Polysomnographic Study to Compare the Efficacy of Gastric Retentive Zaleplon Accordion Pill to Placebo in Subjects With Insomnia
- First Posted Date
- 2011-01-14
- Last Posted Date
- 2014-12-19
- Lead Sponsor
- Intec Pharma Ltd.
- Target Recruit Count
- 83
- Registration Number
- NCT01277107
- Locations
- 🇺🇸
Pacific Sleep Medicine, San Diego, California, United States
🇺🇸Miami Research Associates, Miami, Florida, United States
🇺🇸Broward Research Group, Pembroke Pines, Florida, United States
Comparison of IN 10 003 to Placebo in Subjects With Insomnia Suffering From Difficulty in Falling Asleep and Staying Asleep
- Conditions
- Subjects With Insomnia Suffering From Difficulty in Falling Asleep and Staying Asleep
- Interventions
- Drug: IN 10 003 formulation ADrug: IN 10 003 formulation BDrug: Placebo capsules
- First Posted Date
- 2010-09-08
- Last Posted Date
- 2011-05-03
- Lead Sponsor
- Intec Pharma Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT01196650
- Locations
- 🇮🇱
Soroka University Medical Center, Beer Sheva, Israel
🇮🇱Rambam Medical Center, Haifa, Israel
🇮🇱Assuta Medical Center, Tel Aviv, Israel
- Prev
- 1
- 2
- Next